https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54558 Wed 28 Feb 2024 10:26:26 AEDT ]]> Assessment of the quality of pharmacoeconomic evaluation literature in China https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32473 Wed 06 Jun 2018 14:11:27 AEST ]]> Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14785 Sat 24 Mar 2018 08:26:30 AEDT ]]> A study of the health and economic effects of influenza-like illness on the working population under different working environments of a large corporation in Hong Kong https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5750 Sat 24 Mar 2018 07:45:01 AEDT ]]> Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial) https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5645 Sat 24 Mar 2018 07:44:06 AEDT ]]>